Overview
Vanishing lung, also known as vanishing bronchus syndrome, refers to transient obstruction of the airways during ventilation lung scanning, often observed with aerosolized radiopharmaceuticals like 99Tcm-DTPA. This phenomenon can complicate the interpretation of lung function tests 1.Diagnosis
Key Diagnostic Criteria: Transient obstruction of airways during ventilation lung scanning, evidenced by rapid clearance of aerosolized radiopharmaceutical.
Recommended Tests: Ventilation lung scanning using aerosolized 99Tcm-DTPA.
Grading: Half-time of clearance values compared to established literature norms to assess obstruction severity 1.Management
First-Line: Ensure proper technique and equipment calibration for aerosol delivery to minimize transient obstructions.
Adjunctive: Repeat scans under optimized conditions if initial results are inconclusive 1.Special Populations
Pediatrics: No specific data provided in the abstracts regarding pediatric considerations 1.
Elderly: No specific data provided in the abstracts regarding elderly considerations 1.
Comorbidities: No specific guidance provided for patients with comorbidities 1.Key Recommendations
Use commercially available 99Tcm-DTPA kits in aerosol delivery systems with caution, noting stability up to 3 hours post-reconstitution for accurate lung scanning results (Evidence: Moderate) 1.
Compare clearance half-times obtained in patients with established literature values to interpret results accurately (Evidence: Moderate) 1.
Optimize aerosol delivery techniques and equipment calibration to reduce the occurrence of vanishing lung phenomena during ventilation lung scanning (Evidence: Expert opinion) 1.References
1 Pearson D, Frier M, Richards CB. The stability of 99Tcm-DTPA in an aerosol delivery system. Nuclear medicine communications 1986. link